Article
IDH1 status is significantly different between high-grade thalamic and superficial gliomas.
Cancer biomarkers : section A of Disease markers - 23 Aug 2017
Zuo Mingrong, Li Mao, Chen Ni, Yu Tianping, Kong Bing, Liang Ruofei, Wang Xiang, Mao Qing, Liu Yanhui
Abstract excerpt
BACKGROUND: While major progress has been made in diagnosis and treatment of gliomas based on molecules, molecular features of thalamic glioma have rarely been reported till now. OBJECTIVE: IDH1 mutation is important for prognosis of gliomas and represents a distinctive category of glioma. We intended to survey specific molecular abnormalities in high-grade thalamic gliomas (WHO III-IV). METHODS: We collected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
